Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-01 @ 8:44 AM
Study NCT ID:
NCT00484432
Status:
COMPLETED
Last Update Posted:
2018-09-27
First Post:
2007-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
Sponsor:
AGC Biologics S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NGR012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None